Article Details
Retrieved on: 2024-10-23 23:15:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here